Wed saw a strong rally around the world on news that the FDA is about to approve a drug that can help treat the coronavirus. The week so far also saw some 200 of the top companies reporting Q1 figures that beat or matched expectations. On the surface, it was all good news, however, one needs to put things in perspective... Q1 encompasses 2 boom months of the 3, and a treatment for the coronavirus is not a vaccine nor a cure, it does little to speed the reopening of the economy. Putting all this together and taking on board comments and projections made by the companies that reported, and taking an optimistic 20 multiple on estimated earnings, puts the S&P500 at 2,600, some 12% below current prices.